secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001213900-25-084180
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve merger with Semnur Pharmaceuticals at September 3 meeting
------------------------------------------------------------------------------

- All 9 proposals, including business combination with Semnur, approved by 94.08% quorum.
- Domestication from Cayman Islands to Delaware and amended charter/bylaws approved.
- New board of directors elected: Jaisim Shah, Henry Ji, Jay Chun, Dorman Followwill, Yue Alexander Wu.
- Issuance of >20% of Denali shares and conversion of Semnur options into New Semnur options approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025084180/0001213900-25-084180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025084180/ea0255814-8k_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-084180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer